Introduction
T-cell prolymphocytic leukaemia (T-PLL) is a sporadic and rare disease aecting individuals with no reported signi®cant family cancer history (including Ataxia Telangiectasia (A-T)) (Matutes et al., 1991; Ginaldi et al., 1996; Brito-Babapulle et al., 1987) . It involves a clonal proliferation of T-cells with a characteristic morphology, with a mature immunophenotype and often with karyotypic abnormalities on chromosome 14 (usually as an inversion between 14q11 and 14q32) and on chromosome 8 (usually as isochromosome 8q). The disease has an aggressive course resistant to conventional therapy, but complete remissions can be obtained with a CD52 monoclonal antibody, CAM-PATH-1H (Pawson et al., 1997) .
A-T is a rare familial recessive disorder (reviewed by Hecht and Hecht, 1990, and Taylor et al. 1996) which maps to 11q23.1 (GattõÂ et al., 1988) and that is caused predominantly by truncating mutations in the ATM gene (Savitsky et al., 1995a,b) . A-T has been variously described as a progressive neurological disorder, an immunode®ciency disorder, a chromosomal instability disorder or a DNA repair disorder. A-T families also show elevated cancer risks: A-T heterozygotes are at increased risk for breast cancer (Athma et al., 1996) . In contrast, homozygotes display an elevated risk of cancer at other sites, especially haematological malignancies. B-cell and T-cell malignancies are markedly elevated in homozygotes but, interestingly, not in heterozygotes (Taylor et al., 1996) .
Indirect evidence implicates the ATM gene in T-PLL, as summarized in Table 1 . Substantial morphological, immunophenotypic and karyotypic similarities exist between T-PLL and a mature T-cell leukaemia seen in some older A-T patients . Case reports (Taylor et al., 1996 and references therein) suggest the risk to A-T homozygotes of the latter disease is greater than the risk to the general population of the former. A lower age of onset in A-T homozygotes than in the population is indicated. Breakpoints at chromosome 11q23 ± where ATM maps ± are observed occasionally in T-PLL (VB-B, unpublished observations).
Recently, we have reported nucleotide changes in ATM in just under half of a panel of 37 cases (VorÏ echovskyÂ et al., 1997) . These nucleotide changes ± often missense mutations ± clustered in the 3' end of the gene that encodes the highly conserved kinase domain. At the same time, a signi®cant proportion of nucleotide changes were loss-of-function mutations. Just three of the mutations were identical to reported A-T mutations. These data implicated somatic inactivation of ATM in the development of this sporadic leukaemia and suggested that ATM functions as a tumour suppressor gene in T-PLL. In two cases, two mutations were detected and no signi®cant quantity of wild type allele was observed, suggesting that more than two events aecting ATM had occurred in each case.
In order to investigate this suggestion further and to test for the possible disruption of ATM consistent with karyotyping data, a panel of T-PLL cases was examined by¯uorescent in situ hybridization on DNA ®bres (Fibre FISH). This technique was chosen to examine the ATM locus because it would provide a general overview of both alleles of the ATM locus which spans 150 Kb (Uziel et al., 1996) . Stained ®bres are easier to interpret than Southern blots and, unlike conventional FISH, Fibre FISH does not require metaphase spreads. Here we report structural lesions in addition to nucleotide changes at ATM in T-PLL. A summary of some of these results has been published (Yuille et al., 1996) .
Results

Patient samples
T-PLL cases 1 ± 8 were studied. No patient had a signi®cant cancer family history or A-T relatives. Routine cytogenetic analysis by Giemsa banding was performed (Table 2 ). Lymphocytes separated from peripheral blood samples were cryopreserved at diagnosis and samples of these were available for use in this study. In all cases, the white blood cell count was very high, and the samples were over 95% tumour cells. Cases 3 and 6 were treated with CAMPATH-1H, clinical remission was achieved and cryopreserved separated lymphocytes taken during remission were available.
All tumour samples and both remission samples were analysed for ATM exon mutations using singlestrand conformation polymorphism mutation detection and sequencing ( Figure 1 and Table 3 ).
The structure of the ATM gene was investigated by Fibre FISH. A contig of four cosmids that span the ATM gene was used ± cos B10, cos A12, cos A1 and cos A4 (Figure 2 ). Between cos A12 and cos A1 was a 12 Kb gap in which lie exons 25 and 26. Cos A4 does not include exons 64 and 65. The cosmids were labelled with¯uorochromes so that cos B10 and cos A1 gave red signals, cos A12 gave green signals and cos A4 gave yellow signals. This method and our results were validated by testing DNA ®bres from the lymphocytes of three healthy volunteers with the contig. These gave rise, as expected, to punctate linear signals which, when aligned, showed one pattern of staining: red ± green ± red ± yellow ( Figure  3a ,C). DNA ®bres from tumour samples were hybridized with a cosmid contig spanning a gene ± ETV6 ± not known or suspected to be involved in T-PLL (see Materials and methods) and this also gave rise to the predicted pattern of staining (not shown). DNA ®bres from tumour samples were then hybridized with the four ATM cosmids. (Figure 3a , 2 ± 8). Representative stained ®bres are shown in Figure 3a left and are labelled a, b, c or d. An The characteristics of A-T-related mature T-cell leukaemia are from Taylor et al., (1996) . The characteristics of T-PLL are from BritoBabapulle et al., (1987) and Matutes et al., (1991) , together with unpublished observations (EM, VB-B and DC). A: percentage of 85 T-PLL cases; B: percentage of 60 T-PLL cases Figure 3a right. A collage of the dierent types of ®bre acquired in one case (case 5) is shown ( Figure 3b ) to indicate how Figure 3a left was derived. Using cDNA probes for contiguous segments of the ATM gene (Figure 2 ), all samples were analysed by Southern blotting and Figure 4 shows some of the rearrangements detected.
Case 1
The tumour sample showed loss of chromosome 11. Fibre FISH data was unavailable.
Case 2
Fibre a was normal and ®bres b and c indicated that an allele had undergone ®rstly an inversion between the telomeric end of the cos A4 region at a location close to the telomeric end of the cos A12 region and secondly a translocation or insertion within the cos A4 region. It was not possible to tell whether the breakage within the cos A4 region arose due to a translocation event or a large insertion of non-staining DNA. Both cDNAs refIV and refV identi®ed the same rearrangement. Since the probes overlap in exons 56 and 57, this rearrangement is consistent with the translocation/insertion observed within the cos A4 region.
Case 3
Mutation analysis showed a nucleotide change in ATM exon 61 leading to L2890V at a residue conserved after alignment (Savitsky et al., 1995b) in murine Atm and in the S. cerevisiae tel1p homolog. No wild type allele could be detected. DNA from a remission sample was available: this lacked L2890V. Hence the nucleotide change was somatic. The same mutation has been reported in another T-PLL case, 6b1 (VorÏ echovskyÂ et al., 1997). The C?G transversion was not at a CpG dinucleotide. One type of stained DNA ®bre was identi®ed. This was consistent with the deletion of an entire parental ATM allele; with the presence of indistinguishable structural lesions on both alleles; or with a somatic gene conversion event resulting in two identical alleles. The ®bre lacked staining due to cos A1. Since the exon segments within the cos A1 region were readily ampli®ed and since cDNA probes for the cos A1 region detected no deleted bands, the cos A1 region was probably not deleted from the genome, but had been transposed. The failure to detect a cos A1 staining region may be due to systematic underreporting of shorter fragments (see Materials and methods) and/or due to further structural lesions within the cos A1 region resulting in fragments too short to detect by Fibre FISH. Fibre length measurements gave standard deviations that did not indicate the presence of two similar ®bres. The cos A12 region constituted 63.8% of the length of the ®bre ± about double the fraction seen in normal ®bres. This suggested, most simply, the duplication of the cos A12 region. cDNA refIV identi®ed a new band and a germline band was absent. This probe includes exons 64 and 65 which are not present in cos A4. Therefore another structural lesion was present in the tumour sample, most likely telomeric of cos A4.
Case 4
The tumour sample showed del(11)(q23-q24) and a nucleotide change R3008C was detected in exon 65. This residue is conserved after alignment (Savitsky et al., 1995b) in murine Atm, in the S. cerevisiae tel1p homolog and in the D. melanogaster mei-41 homolog. No wild type allele was detected.
A single type of DNA ®bre was observed, similar to that observed in case 3. This suggested that the cos A1 region was not present in the ®bre, but PCR and Southern blotting were consistent with it having been retained in the genome. Hence, most likely, the cos A1 region was transposed. The standard deviation of the lengths of the ®bres observed did not suggest there was more than one population of ®bres. About 64% of the ®bre stained with cos A12 indicating a duplication within this region. The relative length of cos B10 to cos A4 was 37% of that in normals, indicating a deletion in the cos B10 region. Correlating with a breakpoint at the centromeric end of cos A1, cDNA probe fB2 detected two rearranged bands. But if only one type of ATM ®bre were present, then the gain of two rearranged bands should be matched by the loss of two germline bands (though such losses may go undetected when using cDNA probes). Since this was not apparent, the possibility exists that the duplication involving the cos A12 region led to retention of bands identi®ed by fB2 or that Fibre FISH failed to distinguish two similar ®bres with dierent cos A1 transpositions. Either way, this could give rise to two rearranged bands without loss of germline bands.
Case 5
Mutation analysis showed a 31 base pair deletion removing the 5' splice site and nine bases of exon 41. The mutation is thus predicted to lead to exon-skipping and, since exon 41 has 155 base pairs, to protein truncation. No wild type allele was detected.
Four dierent types of DNA ®bre were dectected. Fibres a and b reconstituted an seemingly normal allele if juxtaposed. Hence a translocation event or a large insertion of non-staining DNA had occurred on one ATM allele between the telomeric end of cos A12 and the centromeric end of cos A1. Fibres c and d were consistent with transposition of the cos A1 region to another locus. The relative length of ®bres stained with cos A12 was shortened indicating the presence of a deletion aecting both copies of this region. Since neither PCR nor Southern blotting indicated the presence of a deletion, either the deletions were nonoverlapping or a region of cos A12 ± too short to be detectable by Fibre FISH ± had been transposed from at least one of the alleles to an unknown locus. 
Case 6
The tumour sample showed add(11)(q23) and mutation analysis identi®ed a point mutation in exon 44 leading to a non-conservative amino acid change E2139G in the S. pombi rad3 homology domain of ATM protein.
No wild type allele was detected. The mutation was somatic since it was not observed in DNA from a remission sample.
Three types of stained DNA ®bre were identi®ed. Fibre a was normal and ®bres b and c were consistent with transposition of the cos A1 region to another locus.
Case 7
Fibre a was intact and ®bres b and c when juxtaposed reconstituted an intact allele, indicating this allele had undergone a translocation or large insertion toward the centromeric end of the cos A1 region.
Case 8
The tumour sample had a translocation on chromosome 11 and a nucleotide change of unknown signi®cance in intron 36. No wild type allele was detected.
Fibres a and b and ®bres c and d, when juxtaposed, reconstituted intact alleles, consistent with two translocations or large insertions of non-staining DNA: respectively in the cos A1 region and in the 12 Kb region between cos A12 and cos A1. cDNA probe fB2 identi®ed a rearrangement correlating with the translocation/insertion associated with ®bres c and d.
Discussion
The cytogenetic observation of occasional 11q23 abnormalities in T-PLL led us to investigate whether the ATM gene was rearranged in this disease. We used Fibre FISH because of its ability to reveal breakpoints over a large region of the genome.
The panel of cases studied was comparable to that reported previously (VorÏ echovskyÂ et al., 1997): nucleotide changes were present in ®ve of eight cases; two of these changes were in the conserved kinase domain; one was predicted to lead to loss-of-function; the changes were associated with loss of wild type allele. None of these has been reported to date either in A-T patients where truncating mutations predominate (a locusspeci®c mutation database is at http://www.vmmc.org/ vmrc/atmtab.txt) nor in over 380 normal Caucasians (VorÏ echovskyÂ et al., 1996b), though L2890V was reported in another T-PLL case (VorÏ echovskyÂ et al., 1997). L2890V from the case 3 tumour sample was absent from the remission sample ± as was E2139G in case 6. Therefore both nucleotide changes had a somatic origin and were not some rare polymorphism. This supports the view of T-PLL as a sporadic disease.
Only three intact ATM alleles were present in seven samples: 11 of the 14 presumptive parental alleles were abnormal or absent. This may be an under-estimate since small deletions, duplications, inversions or transpositions may not be detected by Fibre FISH. A complete analysis will require extensive cloning and sequencing in each case. In four tumour samples, Southern blot rearrangements were detected that correlated with lesions detected by Fibre FISH. Many of the lesions were not observed on blots, re¯ecting the insensitivity of the technique when using cDNA probes. We observed at least one structural lesion at ATM in every T-PLL tumour sample tested. This may indicate that ATM inactivation is essential in T-PLL tumorigenesis and hence why so many A-T patients develop a pre T-PLL lymphocytosis (Taylor et al., 1996) . If ATM inactivation is essential, then this opens up the possibility that the intact allele ± lacking any point mutation ± seen in samples 2 and 7 might have been inactivated by some epigenetic mechanism. In samples 3 ± 5 and 8 Fibre FISH detected no intact ATM allele: normal gene function is abrogated. In these cases, nucleotide changes were also observed, albeit in sample 8, the signi®cance of an intron 36 transition mutation is unclear. This suggests that ATM inactivation is a step in the development of T-PLL and that, conversely, ATM inactivation is unlikely to be tumorigenic solely by the indirect mechanism of generating a mutator phenotype (Bebb et al., 1997) . Our previous report (VorÏ echovskyÂ et al., 1997) proposed ATM as a tumour suppressor in the development of T-PLL and we now report its frequent biallelic inactivation. While this is the hallmark of a tumour suppressor, the question of whether ATM exclusively functions as a tumour suppressor in T-PLL depends in part on discovering whether and how the nucleotide changes we have detected aect ATM protein activity and whether or not these nucleotide changes arise during tumorigenesis before structural lesions occur. These considerations suggest some additional role may exist for ATM in the development of some cases of sporadic T-PLL. Such a role is unlikely in the A-T-related mature T-cell leukaemia since ATM is inactivated from conception.
In samples 3 ± 6, there was evidence consistent with the transposition of the cos A1 region. This may suggest the¯anks of this region are especially labile. Five alleles in samples 2 ± 5 had abnormal ®bres containing two or more mutational events and in three of the samples, a nucleotide change was also present. Since it is unlikely that such a multiplicity of events was fortuitous, it is possible that either the ®rst of these events acted as a premutation (increasing the likelihood of subsequent events), or some unknown predisposing factor acted to promote multiple lesions. The presence of more than one breakage on one allele of a gene has been reported for BCL2 activation in a case of follicular lymphoma and the simultaneous presence of translocations and rearrangements in the BCL2 breakpoint cluster regions has been suggested by restriction map analysis in a signi®cant number of follicular lymphomas (Seite et al., 1993) . Among inactivating mutations, two independent germline events have been reported in two instances of Becker muscular dystrophy at DMD, one of which involved two deletions 1000 Kb apart (Bartlett et al., 1989; Laing et al., 1992) . A high rate of legitimate and illegitimate recombination has been associated with the A-T phenotype itself (Meyn, 1993; Lipkowitz et al., 1990) .
The absence of wild type allele from all tumour samples with nucleotide changes can be explained by a deletion event or a gene conversion event (or, improbably, by the same mutation arising twice). In two samples (3 and 4) the data were not inconsistent with loss of an ATM allele in its entirety. In each of the other samples (5, 6 and 8), the mutated exon was in a region close to a breakpoint in one ®bre, so we could not exclude the possibility of a small deletion associated with the breakpoint. It is interesting that nearly all the T-PLL cases with nucleotide changes that we reported previously (VorÏ echovskyÂ et al., 1997) showed an absence of wild type allele. We are currently investigating these alternative explanations of loss of wild type allele.
The presence of structural lesions at ATM was not re¯ected in Giemsa banding abnormalities on metaphase spreads in most of these cases. This points to the value of Fibre FISH in studying this gene not only in T-PLL but also in other diseases in which ATM may be implicated. The value of using other cytogenetic techniques such as chromosome painting or FISH on metaphase spreads to investigate ATM structural lesions will depend in part on whether or not all the structural lesions are intrachromosomal.
Materials and methods
Patients
The diagnosis of T-PLL in cases 1 ± 8 was made at the Royal Marsden Hospital on the basis of clinical, morphological and immunological features as previously described (Matutes et al., 1991) . Remission was achieved in patients 3 and 6 as described (Pawson et al., 1997) . Samples were stored frozen, in some instances, for several years.
Cytogenetic studies
Cytogenetic studies were performed at the time of diagnosis on peripheral blood cells cultured in RPMI 1640 (Gibco, Grand Island, NY) supplemented with 20% inactivated fetal calf serum (Gibco) in the presence of phytohemagglutinin (PHA: Wellcome, Beckenham, UK), at 0.2 mg/ml or PHA (0.1 mg/ml) plus 12-Otetradecanoylphorbol-13-acetate (Sigma, Poole, UK) at 10 77 mol/ml with and without the addition of 10% lymphocyte-conditioned medium. Cells were harvested after 3, 5 and/or 7 days culture. Trypsin Giemsa banding was performed using standard methods.
Poymerase Chain Reaction (PCR)
Ampli®cations were performed using standard conditions as follows: a 20 ml reaction was performed with 1.5 ± 2 mM MgCl 2 using 1 pmole of each primer, 0.2 U Taq DNA polymerase with 16manufacturer's buer (HT Labs, Cambridge UK), 1 ml of cDNA (or 50 ng DNA) and 125 pM of each dNTP (Promega, Madison WI). The mixture was denatured for 30 s at 948C, annealed for 30 s at 55 ± 658C and the extension reactions was at 728C for 30 ± 60 s. Primers were commercially synthesized (Genosys, Cambridge UK).
Screening for ATM mutations was carried out by PCRbased single-strand conformation polymorphism (SSCP) mutation detection using reagents and conditions as previously described (VorÏ echovskyÂ et al., 1996a,b,c) .
Sequencing of PCR products was performed in both directions using 5 ng PCR product submitted to asymmetric ampli®cation for 25 cycles using ABI FS-Taq polymerase dideoxy sequencing kit (ABI, Warrington UK). The products were fractionated and analysed using the ABI 377 Automated Sequencer and its software.
Fibre FISH
FISH was undertaken as described and DNA ®bres were prepared following Parra and Windle (1993) with modi®cations. A cosmid contig that spans most of the 150 Kb ATM gene was a kind gift of Dr Yossi Shiloh (Tel Aviv University, Israel). The contig consisted of cos B10 (centromeric of ATM through exon 10), cos A12 (exon 8 through exon 24) cos A1 (exon 27 through exon 46) and cos A4 (exon 46 through 63). There is a 12 Kb gap between cos A12 and cos A1 (Figure 3) . Each cosmid was labelled with¯uorochromes so as to give rise respectively to red, green, red and yellow signals on a normal DNA ®bre. To test for the integrity of a region of the genome not implicated in T-PLL, chromosome 12p cosmid probes 179a6, 50f4, 163e7 and 54d5 spanning the ETV6 gene were used (Baens et al., 1995) .
A million fresh or frozen lymphocytes from patients or from healthy volunteers (for controls) were spotted on a slide, allowed to dry and lysed with the slide in a horizontal position. After 5 min, the slide was slowly placed in a vertical position until dry and then ®xed. Probes were nick-translated with biotin-16-dUTP and/or digoxygenin-11-dUTP (Boerhinger Mannheim UK). FISH was performed as previously described with overnight hybridization in 50% deionized formamide/26SSC in a moist chamber at 378C. Slides were washed, blocked, stained with antibodies (streptavidin-¯uorescein isothiocyanate (FITC) (Vector Laboratories, Peterborough, UK) and mouse anti-digoxigenin monoclonal antibody (Boehringer Mannheim, UK), then incubated with biotinylated goat anti-streptavidin (Vector Lab, UK) and rabbit anti-mouse IgG tetramethylrhodamine isothiocyanate (TRITC) conjugate (Sigma, UK) and ®nally with streptavidin FITC (Vector Lab UK) and goat antirabbit IgG TRITC conjugate (Sigma, UK)) and counterstained with DAPI (0.5 mg/ml; Sigma, UK) in Vectashield (Vector Lab). Slides were examined using a Zeiss Axiophot microscope (Carl Zeiss Ltd, Welwyn Garden City, UK), equipped with appropriate ®lters for¯uorescein, rhodamine and DAPI. Images were collected through a Photometrics CCD camera (Photometrics, Tucson, AZ, USA) and captured by IP Lab/SmartCapture software (Digital Scienti®c, Cambridge, UK).
For each sample, experiments were performed in duplicate. Between 10 and 20 images of stained ®bres were identi®ed and acquired. A conservative procedure was adopted of only acquiring images showing unambiguous linear regions of staining. This procedure will tend to under-estimate the frequency of short stained ®bres, especially those that stain with two colours. The ®bres showed punctate staining. Images were sorted and similar ones were aligned. Groups of aligned similar images were arranged to form a collage. On the basis of the collage for each case, an initial interpretation was made using the assumption that the pattern of ®bres observed had arisen as a consequence of the minimum possible number of lesions. The collage was re-arranged to re¯ect this interpretation (as in Figure 3b ). The distance between the most proximal and the most distal signal in each monochromatic region was measured on all stained ®bres and the averages and standard deviations were calculated. Using this data, the interpretation was reconsidered and a ®nal interpretation made.
Southern blotting
DNA was extracted from lymphocytes taken at diagnosis, digested with BamHI, BglII and EcoRI and blots were prepared as described (Dyer et al., 1993) . Blots were probed and re-probed after stripping using cDNA probes prepared from l clone fB2 (exons 27 ± 31) (a kind gift of Dr Y Shiloh, Tel Aviv University, Israel) and from normal RNA using RT ± PCR with primers refI ± refV as described (Savitsky et al., 1995a) and with the following primers: T1: exons 3 ± 8 (AGAGGAGTCGGGATCTGCG and CTCG-CACACTGAATAGCCTTG); T2: exons 8 ± 10 (TGCTGT-TACCAAAGGATGCTG and CAATCTGTA-GCCAAG-GCACAA); T3: exons 10 ± 13 (GTCCCTTGCAAAAG-GAAGAAA and TGGTGTTCACATTCTGGCACG); T4: exons 13 ± 19 (TAGCACAGAAGTGCCTCCAAT and TCTCTCCAGGTTCGTTTGCAT); T5: exons 19 ± 25 (AGGTGGAGGATCAGTCATCCA and GAAGAATCT-CCCTTCGTGTC); T6: exons 24 ± 29 (CAATCATCACCA-AGTTCGCATG and AATTTGCTGGCTCATGTAACG). A rearrangement was identi®ed when a probe revealed a new strongly hybridizing band in at least two restriction digests. This requirement reduces the already restricted sensitivity of cDNA probes since a new strongly hybridizing band may be detected with one restriction enzyme, but only give rise to a weakly hybridizing band with a second enzyme. Hence a rearrangement may be discounted.
